Clinical significance of human kallikrein gene 6 messenger RNA expression in colorectal cancer

Kazuhiko Ogawa, Tohru Utsunomiya, Koshi Mimori, Fumiaki Tanaka, Hiroshi Inoue, Hisashi Nagahara, Sadayuki Murayama, Masaki Mori

Research output: Contribution to journalArticle

82 Citations (Scopus)

Abstract

Purpose: Human kallikrein gene 6 (KLK6) is a member of the human kallikrein gene family, and recent studies have found that many kallikreins have altered expression patterns in various malignancies. The purpose of the current study was to quantify the expression of KLK6 in malignant and benign colorectal tissues and to statistically analyze whether KLK6 expression levels correlate with clinicopathologic variables and prognosis in patients with colorectal cancer. Experimental Designs: Paired colorectal tissue samples from cancerous and corresponding noncancerous tissues were obtained from 63 patients with colorectal cancer who underwent surgical resection. Quantitative analyses of KLK6 mRNA expression were done using real-time quantitative reverse transcription-PCR. Results: KLK6 mRNA overexpression in cancerous tissues compared with normal counterparts was observed in 57 of 63 (90%) patients. The mean expression level of KLK6 mRNA in cancerous tissues was significantly higher than that in noncancerous tissues (P < 0.0001). Elevated KLK6 expression was significantly correlated with serosal invasion (P < 0.05), liver metastasis (P < 0.05), and advanced Duke's stage (P < 0.01), Furthermore, patients with high KLK6 expression had a significantly poorer actuarial overall survival than patients with low KLK6 expression (5-year overall survival rates: 54% and 73%, respectively, P < 0.05), Conclusions: The results of this study indicated that KLK6 mRNA expression was significantly higher in cancerous than in noncancerous colorectal tissues, and high expression of KLK6 mRNA correlated with serosal invasion, liver metastasis, advanced Duke's stage, and a poor prognosis for patients with colorectal cancer.

Original languageEnglish
Pages (from-to)2889-2893
Number of pages5
JournalClinical Cancer Research
Volume11
Issue number8
DOIs
Publication statusPublished - Apr 15 2005

Fingerprint

Kallikreins
Colorectal Neoplasms
Messenger RNA
Genes
Gene Expression
Neoplasm Metastasis
Liver
Reverse Transcription
Research Design

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Clinical significance of human kallikrein gene 6 messenger RNA expression in colorectal cancer. / Ogawa, Kazuhiko; Utsunomiya, Tohru; Mimori, Koshi; Tanaka, Fumiaki; Inoue, Hiroshi; Nagahara, Hisashi; Murayama, Sadayuki; Mori, Masaki.

In: Clinical Cancer Research, Vol. 11, No. 8, 15.04.2005, p. 2889-2893.

Research output: Contribution to journalArticle

Ogawa, Kazuhiko ; Utsunomiya, Tohru ; Mimori, Koshi ; Tanaka, Fumiaki ; Inoue, Hiroshi ; Nagahara, Hisashi ; Murayama, Sadayuki ; Mori, Masaki. / Clinical significance of human kallikrein gene 6 messenger RNA expression in colorectal cancer. In: Clinical Cancer Research. 2005 ; Vol. 11, No. 8. pp. 2889-2893.
@article{8dba015a17fc4220af72611c7e8d9353,
title = "Clinical significance of human kallikrein gene 6 messenger RNA expression in colorectal cancer",
abstract = "Purpose: Human kallikrein gene 6 (KLK6) is a member of the human kallikrein gene family, and recent studies have found that many kallikreins have altered expression patterns in various malignancies. The purpose of the current study was to quantify the expression of KLK6 in malignant and benign colorectal tissues and to statistically analyze whether KLK6 expression levels correlate with clinicopathologic variables and prognosis in patients with colorectal cancer. Experimental Designs: Paired colorectal tissue samples from cancerous and corresponding noncancerous tissues were obtained from 63 patients with colorectal cancer who underwent surgical resection. Quantitative analyses of KLK6 mRNA expression were done using real-time quantitative reverse transcription-PCR. Results: KLK6 mRNA overexpression in cancerous tissues compared with normal counterparts was observed in 57 of 63 (90{\%}) patients. The mean expression level of KLK6 mRNA in cancerous tissues was significantly higher than that in noncancerous tissues (P < 0.0001). Elevated KLK6 expression was significantly correlated with serosal invasion (P < 0.05), liver metastasis (P < 0.05), and advanced Duke's stage (P < 0.01), Furthermore, patients with high KLK6 expression had a significantly poorer actuarial overall survival than patients with low KLK6 expression (5-year overall survival rates: 54{\%} and 73{\%}, respectively, P < 0.05), Conclusions: The results of this study indicated that KLK6 mRNA expression was significantly higher in cancerous than in noncancerous colorectal tissues, and high expression of KLK6 mRNA correlated with serosal invasion, liver metastasis, advanced Duke's stage, and a poor prognosis for patients with colorectal cancer.",
author = "Kazuhiko Ogawa and Tohru Utsunomiya and Koshi Mimori and Fumiaki Tanaka and Hiroshi Inoue and Hisashi Nagahara and Sadayuki Murayama and Masaki Mori",
year = "2005",
month = "4",
day = "15",
doi = "10.1158/1078-0432.CCR-04-2281",
language = "English",
volume = "11",
pages = "2889--2893",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "8",

}

TY - JOUR

T1 - Clinical significance of human kallikrein gene 6 messenger RNA expression in colorectal cancer

AU - Ogawa, Kazuhiko

AU - Utsunomiya, Tohru

AU - Mimori, Koshi

AU - Tanaka, Fumiaki

AU - Inoue, Hiroshi

AU - Nagahara, Hisashi

AU - Murayama, Sadayuki

AU - Mori, Masaki

PY - 2005/4/15

Y1 - 2005/4/15

N2 - Purpose: Human kallikrein gene 6 (KLK6) is a member of the human kallikrein gene family, and recent studies have found that many kallikreins have altered expression patterns in various malignancies. The purpose of the current study was to quantify the expression of KLK6 in malignant and benign colorectal tissues and to statistically analyze whether KLK6 expression levels correlate with clinicopathologic variables and prognosis in patients with colorectal cancer. Experimental Designs: Paired colorectal tissue samples from cancerous and corresponding noncancerous tissues were obtained from 63 patients with colorectal cancer who underwent surgical resection. Quantitative analyses of KLK6 mRNA expression were done using real-time quantitative reverse transcription-PCR. Results: KLK6 mRNA overexpression in cancerous tissues compared with normal counterparts was observed in 57 of 63 (90%) patients. The mean expression level of KLK6 mRNA in cancerous tissues was significantly higher than that in noncancerous tissues (P < 0.0001). Elevated KLK6 expression was significantly correlated with serosal invasion (P < 0.05), liver metastasis (P < 0.05), and advanced Duke's stage (P < 0.01), Furthermore, patients with high KLK6 expression had a significantly poorer actuarial overall survival than patients with low KLK6 expression (5-year overall survival rates: 54% and 73%, respectively, P < 0.05), Conclusions: The results of this study indicated that KLK6 mRNA expression was significantly higher in cancerous than in noncancerous colorectal tissues, and high expression of KLK6 mRNA correlated with serosal invasion, liver metastasis, advanced Duke's stage, and a poor prognosis for patients with colorectal cancer.

AB - Purpose: Human kallikrein gene 6 (KLK6) is a member of the human kallikrein gene family, and recent studies have found that many kallikreins have altered expression patterns in various malignancies. The purpose of the current study was to quantify the expression of KLK6 in malignant and benign colorectal tissues and to statistically analyze whether KLK6 expression levels correlate with clinicopathologic variables and prognosis in patients with colorectal cancer. Experimental Designs: Paired colorectal tissue samples from cancerous and corresponding noncancerous tissues were obtained from 63 patients with colorectal cancer who underwent surgical resection. Quantitative analyses of KLK6 mRNA expression were done using real-time quantitative reverse transcription-PCR. Results: KLK6 mRNA overexpression in cancerous tissues compared with normal counterparts was observed in 57 of 63 (90%) patients. The mean expression level of KLK6 mRNA in cancerous tissues was significantly higher than that in noncancerous tissues (P < 0.0001). Elevated KLK6 expression was significantly correlated with serosal invasion (P < 0.05), liver metastasis (P < 0.05), and advanced Duke's stage (P < 0.01), Furthermore, patients with high KLK6 expression had a significantly poorer actuarial overall survival than patients with low KLK6 expression (5-year overall survival rates: 54% and 73%, respectively, P < 0.05), Conclusions: The results of this study indicated that KLK6 mRNA expression was significantly higher in cancerous than in noncancerous colorectal tissues, and high expression of KLK6 mRNA correlated with serosal invasion, liver metastasis, advanced Duke's stage, and a poor prognosis for patients with colorectal cancer.

UR - http://www.scopus.com/inward/record.url?scp=17144391833&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17144391833&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-04-2281

DO - 10.1158/1078-0432.CCR-04-2281

M3 - Article

C2 - 15837738

AN - SCOPUS:17144391833

VL - 11

SP - 2889

EP - 2893

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 8

ER -